Cite
HARVARD Citation
Shore, N. et al. (2019). Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia. Therapeutic advances in urology. p. . [Online].